Free Trial
OTC:BBLG

Bone Biologics (BBLG) Stock Price, News & Analysis

Bone Biologics logo
$2.94 -0.08 (-2.65%)
As of 07/11/2025 04:00 PM Eastern

About Bone Biologics Stock (OTC:BBLG)

Key Stats

Today's Range
$2.91
$3.04
50-Day Range
$2.94
$6.20
52-Week Range
$2.87
$25.50
Volume
54,333 shs
Average Volume
255,469 shs
Market Capitalization
$1.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BBLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

BBLG Stock News Headlines

BBLG Moves Toward Commercialization
BBLG Splits to Advance
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Bone Biologics Announces Pricing Of $2 Mln Public Offering
See More Headlines

BBLG Stock Analysis - Frequently Asked Questions

Bone Biologics' stock was trading at $5.6418 at the beginning of the year. Since then, BBLG shares have decreased by 47.9% and is now trading at $2.94.

Bone Biologics Co. (OTC:BBLG) announced its earnings results on Monday, August, 14th. The company reported ($10.14) earnings per share for the quarter, missing the consensus estimate of ($9.00) by $1.14.

Bone Biologics shares reverse split on the morning of Tuesday, June 10th 2025.The 1-6 reverse split was announced on Monday, June 9th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 9th 2025. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bone Biologics investors own include Pfizer (PFE), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Advanced Micro Devices (AMD), Canopy Growth (CGC) and Cisco Systems (CSCO).

Company Calendar

Last Earnings
8/14/2023
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTC
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
OTC:BBLG
CIK
1419554
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($49.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-123.44%
Return on Assets
-82.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.95
Quick Ratio
3.95

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.82 per share
Price / Book
1.62

Miscellaneous

Outstanding Shares
545,000
Free Float
2,886,000
Market Cap
$1.60 million
Optionable
Not Optionable
Beta
0.69
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTC:BBLG) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners